Piramal Pharma Share Price

Piramal Pharma (INR)250.6-1.2   (-0.5%)

Exchange ScripsBSE543635NSEPPLPHARMAISININE0DK501011

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Piramal Pharma Performance

Market performance
Open price255.05
High260
Volumes4256286
Prev Close250.6
Low248.55
Closing date2024-11-19
Historical performance
1 Year High307.90
3 Year High307.90
5 Year High307.90
1 Year Low114.35
3 Year Low61.62
5 Year Low61.62

Piramal Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
0
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
1860.43
Dividend Yield
Dividend Yield
N/A

Piramal Pharma Investment Returns

1 Year
114.6%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Piramal Pharma Technicals

IndicatorsValueSignal
5-DMA254.22Bearish
10-DMA268.17Bearish
20-DMA259.56Bearish
50-DMA239.21Bullish
100-DMA206.36Bullish
200-DMA173.39Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1717171717
Foreign Investors---------------
Domestic Investors1717171717
Public Investors359734306381297979292295300589
Government11221

Piramal Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income2011225127581641
Operating Profit1371785331225515921
Interest4485344219821634
Depreciation7406676758625450
Profit Before Tax1793-120248509490
Consolidated Net Profit178-186537608350
Adjusted EPS----238

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1322911933118599946
Total Reserves65610558025510746103
Minority Interest------------
Total Non-Current Liabilities29288381202902625604
Total Liabilities152972144365127172107561
Capital Work in Progress5657852967323995
Total Assets152972144365127172107561

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities10045483976645976
Cash Flow from Investing Activities-4340-13388-18121-44799
Cash Flow from Financing Activitie-42248178794239768
Net Cash Inflow / Outflow1482-371-2515945
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 1860.43.
  • 3Y Stock Price CAGR of the stock is 16.2.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹13717 Million.
  • The company generated revenue of ₹81712 Million in the previous financial year.

Piramal Pharma

250.6-1.2   (-0.5%)

Investment Amount: ₹ 11990
Current Value: ₹ 25060
Performence: 109%
P/L: ₹ 13070
Top Gainers
SymbolChange%
IVP237.15(20%)
JINDWORLD335.6(20%)
ARIES317.95(13%)
MITTAL2(12%)
LOKESHMACH371.45(12%)
Top Losers
SymbolChange%
HONASA264.1(-11%)
MEDICO45.62(-10%)
ASTRON19.26(-10%)
ONELIFECAP14.74(-9%)
KOPRAN207.9(-7%)
WAAREEENER2901.8(-7%)
GVPTECH11.39(-6%)
MAPMYINDIA1647.6(-6%)
Similar stocks

Vimta Labs

31.9

742.45

October 20 - November 20

AMI Organics

27.4

2025.65

October 20 - November 20

Innova Captab

24.9

931.75

October 20 - November 20

Supriya Lifescience

24.4

690.35

October 20 - November 20

Jagsonpal Pharma

24.2

576.6

October 20 - November 20

Unichem Lab

20.3

881.35

October 20 - November 20

Panacea Biotec

14.8

394.3

October 20 - November 20

Dishman Carbogen Amc

10.9

220.01

October 20 - November 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month